Patients with chronic granulomatous disease have a reduced peripheral blood memory B cell compartment

Journal of Immunology

Volumn 176, Issue 11, 2006, Pages 7096-7103

  Bleesing, Jack J ^a   Souto Carneiro, Margarida M ^b,c   Savage, William J ^d   Brown, Margaret R ^e   Martinez, Cynthia ^e   Yavuz, Sule ^c   Brenner, Sebastian ^d   Siegel, Richard M ^c   Horwitz, Mitchell E ^d   Lipsky, Peter E ^c   Malech, Harry L ^d   Fleisher, Thomas A ^e  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD5 ANTIGEN; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL INFECTION; CELL COMPARTMENTALIZATION; CELL FUNCTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; GENE MUTATION; GENOTYPE; GRANULOMA; GRANULOMATOSIS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; IMMUNOPHENOTYPING; MEMORY CELL; PHAGOCYTE; PHENOTYPE; PRIORITY JOURNAL; X CHROMOSOME INACTIVATION;

EID: 33646881800     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.11.7096     Document Type: Article

References (38)

1. Berendes, H., R. A. Bridges, and R. A. Good. 1957. A fatal granulomatous disease of childhood: the clinical study of a new syndrome. Minn. Med. 40: 309-312.
2. Bridges, R. A., H. Berendes, and R. A. Good. 1957. A fatal granulomatous disease of childhood. Am. J. Dis. Child. 97: 387-408.
3. Landing, B. H., and H. S. Shirkey. 1957. Syndrome of recurrent infection and infiltration of viscera by pigmented lipoid histiocytes. Pediatrics 20: 431-438.
4. Segal, B. H., T. L. Leto, J. I. Gallin, H. L. Malech, and S. M. Holland. 2000. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine 79: 170-200.
5. Winkelstein, J. A., M. C. Marino, R. B. Johnston, J. Boyle, J. Curnutte, J. I. Gallin, H. L. Malech, S. M. Holland, H. Ochs, P. Quie, et al. 2000. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine 79: 155-169.
6. Horwitz, M. E., A. J. Barrett, M. R. Brown, C. S. Carter, R. Childs, J. I. Gallin, S. M. Holland, G. F. Linton, J. A. Miller, S. F. Leitman, et al. 2001. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N. Engl. J. Med. 344: 881-888.
7. Malech, H. L., P. B. Maples, N. Whiting-Theobald, G. F. Linton, S. Sekhsaria, S. J. Vowells, F. Li, J. A. Miller, E. DeCarlo, S. M. Holland, et al. 1997. Prolonged production of NADPH-oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proc. Natl. Acad. Sci. USA 94: 12133-12138.
8. Savage, W. J., J. J. Bleesing, D. Douek, M. R. Brown, G. F. Linton, H. L. Malech, and M. E. Horwitz. 2001. Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism. Bone Marrow Transplant. 28: 463-472.
9. + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188: 1679-1689.
10. Agematsu, K., S. Hokibara, H. Nagumo, and A. Komiyama. 2001. CD27: a memory B cell marker. Immunol. Today 21: 204-206.
11. + memory B cell population in X-linked hyper-IgM syndrome. J. Clin. Invest. 102: 853-860.
12. Jacquot, S., L. Macon-Lemaitre, E. Paris, T. Kobata, Y. Tanaka, C. Morimoto, S. F. Schlossman, and F. Tron. 2000. B cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immunocompromised patients. Int. Immunol. 13: 871-876.
13. Bleesing, J. J., and T. A. Fleisher. 2003. Human B cells express a CD45 isoform that is similar to murine B220 and is down-regulated with acquisition of the memory B-cell marker CD27. Cytometry B. Clin. Cytom. 51: 1-8.
14. Dusi, S., K. A. Nadalini, M. Donini, L. Zentilin, F. B. Wientjes, D. Roos, M. Giacca, and F. Rossi. 1998. Nicotinamide-adenine dinucleotide phosphate oxidase assembly and activation in EBV-transformed B lymphoblastoid cell lines of normal and chronic granulomatous disease patients. J. Immunol. 161: 4968-4974.
15. Furukawa, K., R. Tengler, M. Nakamura, A. Urwyler, A. L. de Weck, S. Kanegasaki, and F. E. Maly. 1992. B lymphoblasts show oxides activity in response to cross-linking of surface IgM and HLA-DR. Scand. J. Immunol. 35: 561-567.
16. Suzuki, Y., and Y. Ono. 1999. Involvement of reactive oxygen species produced via NADPH oxidase in tyrosine phosphorylation in human B- and T-lineage lymphoid cells. Biochem. Biophys. Res. Commun. 255: 262-267.
17. - T cells (αβ-DNTCs) in humans with autoimmune lymphoproliferative syndrome. Clin. Immunol. 104: 21-30.
18. Vowells, S. J., S. Sekhsaria, H. L. Malech, M. Shalit, and T. A. Fleisher. 1995. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J. Immunol. Methods 178: 89-97.
19. Vowells, S. J., T. A. Fleisher, S. Sekhsaria, D. W. Ailing, T. E. Maguire, and H. L. Malech. 1996. Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. J. Pediatr. 128: 104-107.
20. -/IgM B cells. J. Clin. Invest. 99: 2488-2501.
21. Souto-Carneiro, M. M., N. S. Longo, D. E. Russ, H. W. Sun, and P. E. Lipsky. 2004. Characterization of the human Ig heavy chain antigen binding complementarity determining region 3, using a newly developed software algorithm JOIN-SOLVER. J. Immunol. 172: 6790-6802.
22. Monson, N. L., T. Dörner, and P. E. Lipsky. 2000. Targeting and selection of mutations in human VL rearrangements. Eur. J. Immunol. 30: 1597-1605.
23. Anderson-Cohen, M., S. M. Holland, D. B. Kuhns, T. A. Fleisher, L. Ding, S. Brenner, H. L. Malech, and J. Roesler. 2003. Severe phenotype of chronic granulomatous disease presenting in a female with a de novo mutation in gp91-phox and a non familial, extremely skewed X chromosome inactivation. Clin. Immunol. 109: 308-317.
24. Van Kooten, C., C. Gaillard, J. P. Galizzi, P. Hermann, F. Fossiez, J. Banchereau, and D. Blanchard. 1994. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur. J. Immunol. 24: 787-792.
25. Van Oers, M. H., S. T. Pals, L. M. Evers, C. E. van der Schroot, G. Koopman, J. M. Bonfrer, R. Q. Hintzen, A. E. von dem Borne, and R. A. van Lier. 1993. Expression and release of CD27 in human B-cell malignancies. Blood 82: 3430-3436.
26. Widney, D., G. Gundapp, J. W. Said, M. van der Meijden, B. Bonavida, A. Demidem, C. Trevisan, J. Taylor, R. Detels, and O. Martinez-Maza. 1999. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma. Clin. Immunol. 93: 114-123.
27. Dörner, T., H. P. Brezinsky, S. J. Foster, R. I. Brezinsky, N. K. Farner, and P. E. Lipsky. 1998. Delineation of selective influences shaping the mutated expressed human immunoglobulin heavy chain repertoire. J. Immunol. 160: 2831-2841.
28. Herzenberg, L. A. 2000. B-1 cells: the lineage question revisited. Immunol. Rev. 175: 9-22.
29. Youinou, P., C. Jamin, and P. M. Lydyard. 1999. CD5 expression in human B-cell populations. Immunol. Today 20: 312-316.
30. + B cells in nonorgan-specific autoimmune diseases: a fresh look. Lupus 10: 523-525.
31. Wouters, C. H., C. Diegenant, J. L. Ceuppens, H. Degreef, and E. A. Stevens. 2004. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship. Br. J. Dermatol. 150: 693-700.
32. Rupec, R. A., T. Petropoulou, B. H. Belohradsky, M. Walchner, J. G. Liese, G. Plewing, and G. Messer. 2000. Lupus erythematosus tumidus and chronic discoid lupus erythematosus in carriers of X-linked chronic granulomatous disease. Eur. J. Dermatol. 10: 184-189.
33. Levine, S., V. V. Smith, M. Malone, and N. J. Sebire. 2005. Histopathological features of chronic granulomatous disease (CGD) in childhood. Histopathology 47: 508-516.
34. Lee, J. R., and G. A. Koretzky. 1998. Production of reactive oxygen intermediates following CD40 ligation correlates with c-Jun N-terminal kinase activation and IL-6 secretion in murine B lymphocytes. Eur. J. Immunol. 28: 4188-4197.
35. phox, a cytosolic subunit of nicotinamide adenine dinucleotide phosphate oxidase. J. Immunol. 172: 231-239.
36. Van Kooten, C., and J. Banchereau. 1997. Functions of CD40 on B cells, dendritic cells and other cells. Curr. Opin. Immunol. 9: 330-337.
37. Cyster, J. G. 2005. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 23: 127-159.
38. Jung, J., J. Choe, L. Li, and Y. S. Choi. 2000. Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10. Eur. J. Immunol. 30: 2437-2443.